Cambrex Corporation (CBM)
Россия
  • Россия
  • Украина

Cambrex Corporation (CBM)

Contact Details

1 Meadowlands Plz # 1510, East Rutherford, New Jersey, USA 07073-2214
(201) 804-3000
1 Meadowlands Plz # 1510, East Rutherford, New Jersey, USA 07073-2214

General Information

Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance enhancers; and polymer systems.

Contact Information

Phone(201) 804-3000
Fax(201) 804-9851
Website 1http://www.cambrex.com
FacebookFacebook
LinkedInLinkedIn
Twitter@cambrex
Thomson Reuters PermID4295905903

Executives

NamePositionTotal Annual CompensationYearPercent Change in Compensation
CEO and President$3,055,843201412.3%
CFO and Executive VP$1,783,661201418.0%
Senior VP, General Counsel and Secretary$919,01120143.6%
COO and Executive VP$2,062,237201419.3%
Subsidiary Managing Director$1,003,2702014-0.1%

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$433 million
Employees1,228

Ownership

Ticker SymbolCBM
ExchangeNew York Stock Exchange (NYSE)
State of IncorporationDelaware
Year Founded1981

Stocks

Previous Close43.27
Open43.36
Bid38.98 x 100
Ask48.00 x 300
Day`s Range42.24 - 43.36
52-Week Range31.12 - 53.82
Average Volume (1M)391,607
Forward P/E18.73x
Trailing P/E24.45x
Beta1.34x
Market Cap.$1,451.32 Million
Last Dividend Amount0
1y Target Price Est.60

Financials

Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue156,18792,979106,63577,525
Cost of Revenue89,92657,29960,69048,446
Gross Profit66,26135,68045,94529,079
Research Development3,5103,6722,7032,655
Selling General and Administrative16,04913,98914,07813,751
Depreciation and Amortization----
Other Operating Expenses15,573---
Total Operating Expenses125,05874,96077,47164,852
Other Income/Expenses Net----
Earnings Before Interest and Taxes31,12918,01929,16412,673
Interest Expense232517474476
Income Before Tax31,30217,20628,92212,135
Income Tax Expense13,8205,3309,4723,767
Minority Interest----
Net Income from Continuing Ops17,48211,87619,4508,368
Discontinued Operations332(129)213(375)
Extraordinary Items----
Effect of Accounting Changes----
Other Items----
Net Income17,81411,74719,6637,993
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares17,81411,74719,6637,993